{"name":"Verily Life Sciences","slug":"verily","ticker":"PRIVATE","exchange":"Private (Alphabet subsidiary)","domain":"verily.com","description":"Verily Life Sciences LLC also known as Verily, is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, and as of December 2024, is operating as a standalone company under Alphabet.","hq":"South San Francisco, CA","founded":0,"employees":"","ceo":"Stephen Gillett","sector":"Health Technology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private (~$10B valuation)","metrics":{"revenue":500000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Onduo patent cliff ($100M at risk)","drug":"Onduo","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2022-02-14","type":"deal","headline":"Verily Life Sciences Raises $1 Billion in Funding","summary":"Verily Life Sciences has raised $1 billion in funding from investors, including major pharmaceutical companies and venture capital firms.","drugName":"","sentiment":"positive"},{"date":"2021-05-25","type":"regulatory","headline":"Verily Life Sciences Receives FDA Clearance for Its Diabetes Management Platform","summary":"Verily Life Sciences has received FDA clearance for its diabetes management platform, which uses artificial intelligence and machine learning to help patients manage their condition.","drugName":"","sentiment":"positive"},{"date":"2020-02-03","type":"earnings","headline":"Verily Life Sciences Announces Strong Revenue Growth in 2019","summary":"Verily Life Sciences has announced strong revenue growth in 2019, driven by the success of its diabetes management platform and other products.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9CTnBzWDZoeHFNa1hLWkFhTUJRMVFlMDBSVGxLWXdZX01PV0I1WGMxaS1nZzB2ZTVRbUo0czV1WnFsbDd3T2FuUHMzNnhxa3NQUVlUV2N4Y2tWS1pqQVYzaUkyakU5SHo3MmUwczF4ZjhxX2JxOEdEc2Y0S1EwUEE?oc=5","date":"2026-03-25","type":"pipeline","source":"pharmaphorum","summary":"AI in drug discovery and development: news watch - pharmaphorum","headline":"AI in drug discovery and development: news watch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE5pOWQybEpESVFSdXgyOWpEem5LcnRwQWlDOXFNM0syQjBvb0RGN1prRml1UmNvX3VtSk1RbldmVlNLTk43VWNSZDlEeW1lUnZrZFAyTUxlU3Q?oc=5","date":"2025-09-02","type":"pipeline","source":"Fierce Pharma","summary":"Verily - Fierce Pharma","headline":"Verily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQa2tJT0JsZWk1M2lKWjFJWkM0US1kUE5NN3Izdmh2RDF5OHh6TlJvbUhBVFFkcHVvYlRpNThXOEptekdYYUxOY19NbXVncHdtb3Q2OGhtbG0tZzZ6YTAtdm9pQlpNTDVMYlAyOEtuT1NkdkNnVEJLYkpKd0RiUVZ0X0RUMzEtNnZ2dlR1VDd5cVZpcE04SjZsZmlmNTRuRHlfSVFF?oc=5","date":"2025-04-02","type":"regulatory","source":"BioSpace","summary":"FDA Job Cuts, Key Departures Bring ‘Revolving Door’ Debate Front and Center - BioSpace","headline":"FDA Job Cuts, Key Departures Bring ‘Revolving Door’ Debate Front and Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQTThvTTVveVNVeDlxR3hrV2FLRnRHSVVzMUthcFNmenJ6VldYdDNlVHNORVBJX2tOV2luWk1QTF85SUw1dVhjZXZQM3BoQ2tXNUhBZDlqbGJUUXZqaXBHc3dVcm1EYjdmMm1fTHJJNWgyZkJtbm5NY3ROM2RRLWlyTDJJNkNudlF4OE4zVEJEbmF6R1FDTERqS2VTX0s?oc=5","date":"2024-09-10","type":"trial","source":"statnews.com","summary":"Former Verily executives hatch plan to invest millions in high-tech medical data - statnews.com","headline":"Former Verily executives hatch plan to invest millions in high-tech medical data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNaGJEUTl0M0lvbzFHUjZjSU90X0NsNElXQjZibWNBUW1LLUhLLUtLak1OWW5PTl9GcDJVVDczQ3F3Tko1UkQ0Ni1jeEkxZkV6cDdTdVNWMTNrY3JsUG93dXJOTmJOZ045LXRKMmFqcTBvOXdrdFQ1ZTVEbU1YYlRxS2U2azl4a2xSVVdfVmFFc29xeEVkU2Z5c1RvWEpzSzR3VnJhb09FcGM1SUYxUjB2RTNSN0hhNW8?oc=5","date":"2021-06-07","type":"regulatory","source":"Bloomberg Law News","summary":"Verily Gig for Former FDA No. 2 Offers Path to Better Research - Bloomberg Law News","headline":"Verily Gig for Former FDA No. 2 Offers Path to Better Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPSUxlVzF2Smh3RDFOeE13aHM4U25NVVNuOVRJX1JtemVWblRLV2l2amdWM29zazJ6aXg1QlIzMVRVeVRsTHVNeFdGWjRQY21UdEhXT3AzRjd2ZVNJaGh6UFF6MHZCSWY3cW5pUTJZODlKR2lZODFHRjl6QkpNTkpQNEQ0aUd0c3hjSlBLX2xhV1VtUQ?oc=5","date":"2020-06-09","type":"pipeline","source":"Frontiers","summary":"Creeping Through the Backdoor: Disruption in Medicine and Health - Frontiers","headline":"Creeping Through the Backdoor: Disruption in Medicine and Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOczdra3Q4QTdUdnJUQjJ4SU5qMnVON0szVC10YmpiQ0tHTWZVQU95X1lDM0t0RHhDaGhFalQyeHU3S0dlQmN2V0ZzRWRuVjVlcVlYY1lIVm8wLXNjWGVFVTEyNkdPRnJVMlF6TkFia1RHR2tXUC1qczB5dTRqTDFnSWthdTFNRW9HN09meDV3azc4ZTdSRWJuYVg1WjVLLV91NEdpYkttSkxJeHVi0gGyAUFVX3lxTFAxWGM4emJVUll2TVdZcDFwaXZ1V1JTMkRmSHp6YTlpWWN3MUlpRzZxUW1FT3RzYVV2YmFnalNNSlA5TUc2NkxIUzkycnU4bGlnRVdELTFRVGRCdFp2UWJFU0VXcDNaYWg5Mm03RGNsSGgzMlVvemVKSXpid1VOZnBBZzlmcG44enV2a3RSLVRlXzdoTnRKdXJFZklyUjZ1N21NcWdCZWhIY3E2NWQ0MGIxaEE?oc=5","date":"2020-05-18","type":"pipeline","source":"ABC News","summary":"Coronavirus vaccine czar to divest some holdings amid conflict concerns - ABC News","headline":"Coronavirus vaccine czar to divest some holdings amid conflict concerns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPQmRjR3ZfZXpjeFYxRXMxemt6TkdzcURRUmJpZHJfZWR0MTZCckJ3SHhvRi1iM1hEb3FxY01VcS1Sc29BRDViZU5QWU9tSzJ4cFBicGhVVWt6bFZTRktoQmI0UTJpZ01aRXhkRUVMclY4YjRrZ3YyLUNDMDdqY3JRd2tIMVZxQnNCdUt5T3YxYm5qZldyLW5YbDI1WFNPVFkzblVJY9IBqgFBVV95cUxNRjd2NEsyQUViRGtGdDJZNk9aM2NWVllXLVVWbGdCR2YyTzN1c3A2WkhmSENZWjZ0akU0ODBHRk4waERmdTA4YTY4SlBzNjB2OUx5WnhrUGZFNy1CT3J4bV9SbjlTSWtDT0ZyUkRqSEVORmxxVW1Cb0Y4aEZrMVJ6YnZ0Y0VSREVETlQ2R1hlSFNLXzVVUDNfVmI1T1RVbVlNcEpJTlhzQW1pUQ?oc=5","date":"2019-05-21","type":"trial","source":"CNBC","summary":"Google sister-company Verily is teaming with big pharma on clinical trials - CNBC","headline":"Google sister-company Verily is teaming with big pharma on clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNSUlrdmpkNWhKLU4yMGxmSnMtNV84aTlKZzhOcEtBTmN0WXliWFlHdmV0VS1QMUZyWV9RcmZreElqMXFHemVGenMyTEU2VWZnLXBlWFhnQnRTNUxqWWhCU2pMUHJ4TXJWYUxxMnYyOHRDeWNhekFaaDZ1ZUdhcl9Vd2lBMzg4T3Z6QmU1TnRtTjV6ZEZoSDJNQkZ1a3lpZ9IBowFBVV95cUxPclNtdXViZW5iN3YxOVJBUkowQ2pHdkpRa0dOZE1yV2ZIMmhFTlNFS3lFNHEyWEpOalY3T1prck1GVlA1MjZPTnlZUmJNbl9pdlhmb2JWN0VMZF9HNVh0b0NTd0twY2R2YWxXX0lEODIwXzZiNEs1LVhsYmFMRFV6SUp3NVo2TW1XRUFJMDlscnVFOUMyY3l1Tno0YllNZzdiR2tV?oc=5","date":"2019-05-21","type":"pipeline","source":"CNBC","summary":"Lazard's Orszag says it's a 'wild time' in health care as technology pressures companies to evolve - CNBC","headline":"Lazard's Orszag says it's a 'wild time' in health care as technology pressures companies to evolve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNUU1UbHBWM0k5b2lKX3RZRW50LXYwd24zLUlvWkhIelZPdTRTZU5FVGtHVGZxRklsQ1hTTmZYX0pMOWZ4a2RjUXJnZjd5MEtILTBRUmxZSmw0U0NXTEJXd2Z5ckFHYmtYYWt6Zk1NSDhsN2FRQ1VPVzNFcXV3UktWNmJTSlZHdFhOSXhXMG9zQ1RqX192Z0w1bENwcTN4MWkyMzNIVzU0cTdnUVllcWJQYUdIZzNzV2tvR0FucjIwaVlkQTZiVnc?oc=5","date":"2019-01-03","type":"pipeline","source":"Reuters","summary":"Alphabet's life science tech unit Verily raises $1 billion from investors - Reuters","headline":"Alphabet's life science tech unit Verily raises $1 billion from investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPRVhBVGFRM0tEN05qZHdKU29EWmczYXluVVRaYXhudmNKTkdKY3lyTUhKZl9uTFdENUswU051bVFWRkRpaktDZWQ3V0lsbEZvMFlaM05CM3cyWWN6VzU0dVRTMjFIYlVVZW03cFJTWG43Z1hBbVdCcno3a3Z6VDBLSnl4c0hNeWNKZnFnX3ZIV1BpTWo0NGdkNnVJOUVSZExJOWRuRDNwcHAzcUhIZDJsYTBkNURaeVk?oc=5","date":"2016-08-01","type":"pipeline","source":"inc.com","summary":"Google Parent Alphabet and GlaxoSmithKline Create $714 Million Joint Venture - inc.com","headline":"Google Parent Alphabet and GlaxoSmithKline Create $714 Million Joint Venture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFB2ZmQxWlQtSDRlS25FWjhfWGFFcXJKTDNYVzNWbm5xR3JHeXVXUkl0R3ZyU1o2LU1TLUdCTmRrYktab1RyNndhV08xNzE5eDhJdy1rOFVGeWwycF9WSm0zLXBOM3hTTEJ4VGcwN3FCYWs0Zw?oc=5","date":"2016-03-28","type":"pipeline","source":"statnews.com","summary":"Verily, Google’s bold bid to transform medicine, hits turbulence under a divisive CEO - statnews.com","headline":"Verily, Google’s bold bid to transform medicine, hits turbulence under a divisive CEO","sentiment":"neutral"}],"patents":[{"drugName":"Onduo","drugSlug":"onduo","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Onduo","Livongo","Roche"],"therapeuticFocus":["Diabetes Management","Cardiovascular Disease","Oncology"],"financials":null,"yahoo":null}